Evidence map›Paper›PMID 37620555›Full record

ArticleScientific reports2023

Deep learning based on dynamic susceptibility contrast MR imaging for prediction of local progression in adult-type diffuse glioma (grade 4).

Donggeon Heo, Jisoo Lee, Roh-Eul Yoo, Seung Hong Choi, Tae Min Kim, Chul-Kee Park, Sung-Hye Park, Jae-Kyung Won, Joo Ho Lee, Soon Tae Lee and 5 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 3 pooled it
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 3 syntheses or guidelines pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 4 countries.

Donggeon Heo *Department of Radiology, Seoul National University College of Medicine, Seoul, Republic of Korea.
Jisoo Lee *Department of Radiology, Seoul National University College of Medicine, Seoul, Republic of Korea.
Roh-Eul YooDepartment of Radiology, Seoul National University College of Medicine, Seoul, Republic of Korea. roheul7@gmail.com.
Seung Hong ChoiDepartment of Radiology, Seoul National University College of Medicine, Seoul, Republic of Korea. verocay1@snu.ac.kr.
Tae Min KimDepartment of Internal Medicine, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
Chul-Kee ParkDepartment of Neurosurgery, Biomedical Research Institute, Seoul National University College of Medicine, Seoul, Korea.
Sung-Hye ParkDepartment of Pathology, Seoul National University College of Medicine, Seoul, Korea.
Jae-Kyung WonDepartment of Pathology, Seoul National University College of Medicine, Seoul, Korea.
Joo Ho LeeDepartment of Radiation Oncology, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
Soon Tae LeeDepartment of Neurology, Seoul National University College of Medicine, Seoul, Korea.
Kyu Sung ChoiDepartment of Radiology, Seoul National University Hospital, 101, Daehangno, Jongno-Gu, Seoul, 03080, Republic of Korea.
Ji Ye LeeDepartment of Radiology, Seoul National University Hospital, 101, Daehangno, Jongno-Gu, Seoul, 03080, Republic of Korea.
Inpyeong HwangDepartment of Radiology, Seoul National University Hospital, 101, Daehangno, Jongno-Gu, Seoul, 03080, Republic of Korea.
Koung Mi KangDepartment of Radiology, Seoul National University Hospital, 101, Daehangno, Jongno-Gu, Seoul, 03080, Republic of Korea.
Tae Jin YunDepartment of Radiology, Seoul National University Hospital, 101, Daehangno, Jongno-Gu, Seoul, 03080, Republic of Korea.
Seoul National University · KRSeoul National University Hospital · KRInstitute for Basic Science · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adult-type diffuse glioma (grade 4) has infiltrating nature, and therefore local progression is likely to occur within surrounding non-enhancing T2 hyperintense areas even after gross total resection of contrast-enhancing lesions. Cerebral blood volume (CBV) obtained from dynamic susceptibility contrast perfusion-weighted imaging (DSC-PWI) is a parameter that is well-known to be a surrogate marker of both histologic and angiographic vascularity in tumors. We built two nnU-Net deep learning models for prediction of early local progression in adult-type diffuse glioma (grade 4), one using conventional MRI alone and one using multiparametric MRI, including conventional MRI and DSC-PWI. Local progression areas were annotated in a non-enhancing T2 hyperintense lesion on preoperative T2 FLAIR images, using the follow-up contrast-enhanced (CE) T1-weighted (T1W) images as the reference standard. The sensitivity was doubled with the addition of nCBV (80% vs. 40%, P = 0.02) while the specificity was decreased nonsignificantly (29% vs. 48%, P = 0.39), suggesting that fewer cases of early local progression would be missed with the addition of nCBV. While the diagnostic performance of CBV model is still poor and needs improving, the multiparametric deep learning model, which presumably learned from the subtle difference in vascularity between early local progression and non-progression voxels within perilesional T2 hyperintensity, may facilitate risk-adapted radiotherapy planning in adult-type diffuse glioma (grade 4) patients.

Indexed as

Deep LearningGliomaMultiparametric Magnetic Resonance ImagingAdultHumansMagnetic Resonance AngiographyMagnetic Resonance Imaging

Identifiers

PMID37620555
PMCPMC10449894
OpenAlexW4386136455

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.